Caricamento...
Nivolumab-Induced Autoimmune-Like Cholestatic Hepatitis in a Liver Transplant Recipient
Cancer treatment has taken giant strides in recent years with the advent of immunotherapy, including checkpoint inhibitors. The use of these medications in liver transplant recipients has been debated, and the added effect of previous hepatitis C infection on the immune system in this setting, is po...
Salvato in:
| Pubblicato in: | ACG Case Rep J |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wolters Kluwer
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7363460/ https://ncbi.nlm.nih.gov/pubmed/32766358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/crj.0000000000000416 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|